- Home
- MREO vs PXLW Comparison
MREO vs PXLW Comparison
Compare MREO & PXLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MREO | PXLW |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.3M | 41.3M |
| IPO Year | 2017 | 2000 |
Fundamental Metrics
Financial Performance| Metric | MREO | PXLW |
|---|---|---|
| Price | $0.34 | $6.05 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $1.96 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 22.6K |
| Earning Date | 11-09-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ 12.07 |
| Revenue | $500,000.00 | ★ $693,000.00 |
| Revenue This Year | N/A | $58.73 |
| Revenue Next Year | N/A | $63.64 |
| P/E Ratio | ★ N/A | $0.50 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.20 | $4.84 |
| 52 Week High | $2.37 | $15.36 |
Technical Indicators
Market Signals| Indicator | MREO | PXLW |
|---|---|---|
| Relative Strength Index (RSI) | 54.00 | 37.90 |
| Support Level | $0.35 | $5.64 |
| Resistance Level | $0.35 | $6.46 |
| Average True Range (ATR) | 0.04 | 0.28 |
| MACD | -0.00 | -0.11 |
| Stochastic Oscillator | 47.31 | 14.25 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.